title: Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure.
authors.forename: Wing-Yan
authors.initials: WY
authors.lastname: Au
authors.forename: Chi-Leung
authors.initials: CL
authors.lastname: Liu
authors.forename: Sidney
authors.initials: S
authors.lastname: Tam
authors.forename: Bonnie M W
authors.initials: BM
authors.lastname: Fong
authors.forename: Tony W
authors.initials: TW
authors.lastname: Shek
authors.forename: Chee-Kin
authors.initials: CK
authors.lastname: Hui
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000628:therapy*; D006515:Hepatitis B virus; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000150:complications / Q000628:therapy*; D017093:Liver Failure / Q000097:blood / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D010087:Oxides / Q000008:administration & dosage*; D012367:RNA, Viral / Q000097:blood; D013997:Time Factors; D014184:Transplantation, Homologous; D014775:Virus Activation / Q000187:drug effects
chemical_list: D001152:Arsenicals; D010087:Oxides; D012367:RNA, Viral; D000077237:Arsenic Trioxide